These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12469001)

  • 21. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
    Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
    Brusa L; Orlacchio A; Moschella V; Iani C; Bernardi G; Mercuri NB
    Mov Disord; 2009 Jan; 24(1):126-9. PubMed ID: 19170197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrabenazine: for chorea associated with Huntington's disease.
    Scott LJ
    CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington's disease.
    Moondra P; Jimenez-Shahed J
    Expert Rev Neurother; 2024 Sep; 24(9):849-863. PubMed ID: 38982802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Schultz JL; Killoran A; Nopoulos PC; Chabal CC; Moser DJ; Kamholz JA
    Neurology; 2018 Jul; 91(3):e202-e207. PubMed ID: 29925548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of tetrabenazine in hyperkinetic movement disorders.
    Jankovic J; Beach J
    Neurology; 1997 Feb; 48(2):358-62. PubMed ID: 9040721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study.
    Kertesz DP; Swartz MV; Tadger S; Plopski I; Barak Y
    Clin Neuropharmacol; 2015; 38(1):23-5. PubMed ID: 25580924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Hunter C; Jankovic J
    Mov Disord; 2007 Jan; 22(2):193-7. PubMed ID: 17133512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review.
    Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW
    J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J; Orman J
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Huntington's disease.
    Frank S
    Neurotherapeutics; 2014 Jan; 11(1):153-60. PubMed ID: 24366610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial.
    Remington G; Kapur S; Foussias G; Agid O; Mann S; Borlido C; Richards S; Javaid N
    J Clin Psychopharmacol; 2012 Feb; 32(1):95-9. PubMed ID: 22198452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.
    Claassen DO; Philbin M; Carroll B
    Expert Opin Pharmacother; 2019 Dec; 20(18):2209-2221. PubMed ID: 31613641
    [No Abstract]   [Full Text] [Related]  

  • 37. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrabenazine in the treatment of severe pediatric chorea.
    Chatterjee A; Frucht SJ
    Mov Disord; 2003 Jun; 18(6):703-6. PubMed ID: 12784277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-World Experience With Deutetrabenazine for Huntington Disease Chorea.
    Curtis K; Sung V
    J Clin Pharmacol; 2024 Feb; 64(2):178-181. PubMed ID: 37565322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
    Frank S; Testa C; Edmondson MC; Goldstein J; Kayson E; Leavitt BR; Oakes D; O'Neill C; Vaughan C; Whaley J; Gross N; Gordon MF; Savola JM;
    CNS Drugs; 2022 Nov; 36(11):1207-1216. PubMed ID: 36242718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.